FDA Inspection 807638 — Glaxo Wellcome Manufacturing Pte Limited
The FDA completed an inspection of Glaxo Wellcome Manufacturing Pte Limited on Nov 16, 2012 in Singapore. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 16, 2012
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Singapore (Singapore)